# Mid-HDF Randomized Controlled Study on Outcome

Study · id `cardio:ct-nct01693354` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01693354](<https://clinicaltrials.gov/study/NCT01693354>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01693354

Browse, organ or system: Kidneys  
Browse, condition area: Kidney connections  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It enrolled 500 participants.

## Technical summary

Registry record NCT01693354. Randomized; no masking; primary purpose treatment. Start 2012-09 (registry gives no type); primary completion 2017-09 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 500 participants (enrolled count; ClinicalTrials.gov record NCT01693354, source copy `cardio:ctgov-nct01693354-2017-01-13`, retrieved 2026-10-26)
- Start date: 2012-09 (registry gives no type) (ClinicalTrials.gov record NCT01693354, source copy `cardio:ctgov-nct01693354-2017-01-13`, retrieved 2026-10-26)
- Primary completion: 2017-09 (anticipated) (ClinicalTrials.gov record NCT01693354, source copy `cardio:ctgov-nct01693354-2017-01-13`, retrieved 2026-10-26)
- Completion: 2018-09 (anticipated) (ClinicalTrials.gov record NCT01693354, source copy `cardio:ctgov-nct01693354-2017-01-13`, retrieved 2026-10-26)
- Countries: Belgium; France; Italy; Spain (ClinicalTrials.gov record NCT01693354, source copy `cardio:ctgov-nct01693354-2017-01-13`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01693354-2017-01-13`, retrieved 2026-10-26)

## The registry's words

- Brief title: Mid-HDF Randomized Controlled Study on Outcome
- Acronym: MILESTONE
- Condition: End Stage Renal Disease
- Intervention (Device): Mid-dilution HDF
- Intervention (Device): HF dialysis
- Lead sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Chronic kidney disease (CKD) (`cardio:chronic-kidney-disease`)
- Registry lists this organization as the lead sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna (`cardio:org-irccs-azienda-ospedaliero-universitaria-di-bologna`)

## Provenance

Content hash: fe9010fe343b0b8c53e872805770424b64abc6de487503f5e2a53fe0cbccadef
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
